胰岛素抵抗对头颈部鳞状细胞癌无病生存的预后意义:初步结果
该研究纳入71例未经治疗的头颈部鳞状细胞癌(HNSCC)患者,在诊断时采集血浆,评估空腹胰岛素、血糖、糖化血红蛋白及稳态模型胰岛素抵抗指数(HOMA-IR)对无病生存的预后价值。结果显示,高HOMA-IR与中晚期肿瘤患者较差的无病生存相关;多因素分析中HOMA-IR>2.974者预后不良风险为2.7倍(95%CI 1.023-7.341;P=.045)。结论认为HOMA-IR与HNSCC无病生存独立相关,并给出了中晚期HNSCC患者无病生存的最佳HOMA-IR截断值。
要点
- 治疗前高HOMA-IR与中晚期HNSCC患者较差的无病生存相关。
- HOMA-IR>2.974者预后不良风险为2.7倍(95%CI 1.023-7.341;P=.045)。
- HOMA-IR与HNSCC无病生存独立相关,或可作为预后参考指标。
核心结论
- HOMA-IR与头颈部鳞状细胞癌患者的无病生存独立相关。
- 研究确定了中晚期HNSCC患者无病生存的最佳HOMA-IR截断值。
研究设计与样本
- 研究纳入71例未经治疗的头颈部鳞状细胞癌患者。
- 在诊断时采集血浆样本。
- 评估空腹胰岛素、血糖、糖化血红蛋白水平及HOMA-IR对无病生存的预后价值。
主要发现
- 高HOMA-IR水平与中晚期肿瘤患者较差的无病生存相关。
- Kaplan-Meier曲线显示高HOMA-IR患者无病生存率低于低水平患者。
- 中晚期肿瘤患者多因素分析中,HOMA-IR>2.974者预后不良风险为2.7倍(95%CI 1.023-7.341;P=.045)。
关键数值与推荐
- 中晚期HNSCC患者中,HOMA-IR>2.974与预后不良风险升高相关(HR约2.7,95%CI 1.023-7.341;P=.045)。
临床怎么用
- 对中晚期HNSCC患者可考虑检测治疗前HOMA-IR以辅助预后评估。
- HOMA-IR>2.974可作为中晚期HNSCC患者无病生存的风险分层参考。
局限性
- 该研究为初步结果,样本量为71例。
- 结论需更大样本研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The primary purpose of this study was to investigate the significance of pretreatment glycemic parameters in the prognosis of head and neck squamous cell carcinoma (HNSCC). METHODS: Plasma samples of 71 patients with untreated HNSCC were obtained at the time of diagnosis. The prognostic value of fasting insulin, glucose, glycosylated hemoglobin levels, and the homeostatic model of risk assessment-insulin resistance (HOMA-IR) was evaluated toward disease-free survival. RESULTS: High HOMA-IR levels were associated with poor disease-free survival in intermediate-advanced stage tumors. Kaplan-Meier curves showed lower disease-free survival rates in patients with high HOMA-IR than in patients with low levels. In patients with intermediate-advanced stage tumors, multivariate analysis revealed that those with an HOMA-IR >2.974 presented a 2.7 times higher risk of poor outcome (95% confidence interval [CI] 1.023-7.341; P = .045). CONCLUSION: The HOMA-IR is independently associated with disease-free survival in patients with HNSCC. We found an optimal HOMA-IR cutoff value for disease-free survival in patients with intermediate-advanced HNSCC.
引用
- Avilés-Jurado FX, Flores JC, Gumà J, et al. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results. Head Neck. 2017. PMID: 28963801. doi:10.1002/hed.24919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。